Testing effectiveness (Phase 2)Study completedNCT03345810
What this trial is testing
Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)
Who this might be right for
Carcinoma, Non-Small-Cell LungMetastatic Lung CancerNon Small Cell Lung Cancer+2 more
AIO-Studien-gGmbH 200